Clinical Study of Qingpeng Ointment in Treating Shoulder Syndrome During Rehabilitation Period of Cerebral Hemorrhage

• Status: Unknown status
• Trial end date: 2019-12-31
• Target enrollment: 0
• Participant gender: All

Summary

A randomized, controlled study is conducted. 120 patients with post-stroke shoulder-shoulder syndrome who meet the inclusion criteria are randomized into treatment group and control group, 60 patients in each group. The treatment group is treated with Qingpeng ointment. The goal of this trial is to verify the clinical efficacy of Tibetan medicine Qingpeng ointment in improving post-stroke shoulder-hand syndrome, and to investigate its effect on pain level, swelling degree, hand movement function, activity and activities of daily living.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Guangzhou University of Traditional Chinese Medicine

Criteria

Inclusion Criteria:

1. Meet the diagnostic criteria for stroke;

2. Meet the diagnostic criteria for shoulder-hand syndrome, stage I

3. The course of disease is between 15 days and 6 months;

4. Consciousness, no serious cognitive impairment, with examination and treatment;

5. Age between 20 and 80 years old;

6. Sign the informed consent form and volunteer to participate in the study.

Exclusion Criteria:

1. Repeated stroke patients or shoulder-hand syndrome patients with repeated attacks or exacerbations;

2. The course of stroke is >6 months;

3. Those with serious heart, liver and kidney diseases and moderate to severe infections;

4. Unconsciousness or a combination of incompetent cognitive impairment and complete aphasia.

5. Take painkillers or other treatments that treat shoulder pain.